{"id": "1359075962105790465", "creation": 1612863934.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": ".@AstraZeneca Stock Is Still a 'Buy' But Not Because of its COVID-19 Vaccine\n\nLuckily $AZN never intended to profit from #COVID19 as their #vaccine developed with Oxford University faces a number of uphill battles\n\n$NVAX $JNJ $INO $VXRT #stocks #trading\n\nhttps://t.co/PWTvCL0lmS", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCKS", "#TRADING"]}